Journal Information
Vol. 43. Issue 1.
Pages 40-45 (January 2007)
Share
Share
Download PDF
More article options
Vol. 43. Issue 1.
Pages 40-45 (January 2007)
Review Article
Full text access
Oxygen-Conserving Systems: A Forgotten Resource
Visits
8244
Diego Castillo
Corresponding author
dcastillo@santpau.es

Correspondence: Dr. D. Castillo. Departamento de Neumología. Hospital de la Santa Creu i Sant Pau. Sant Antoni M. Claret, 167. 08025 Barcelona. Espafia
, Rosa Güell, Pere Casan
Departamento de Neumología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics

Oxygen-conserving devices include transtracheal catheters, reservoir cannulas, and demand oxygen delivery systems. They are designed to extend the amount of time portable oxygen cylinders will last and correct hypoxemia with a lower flow of oxygen. Transtracheal catheters increase the fraction of inspired oxygen by delivering oxygen directly to the trachea, bypassing the dead space of the oropharynx and improving the efficiency of the upper airway as a reservoir. Reservoir cannulas increase the fraction of inspired oxygen at the beginning of the inspiratory phase. Demand oxygen delivery systems have a valve that is activated during inspiration, meaning that oxygen is only delivered during this stage of the respiratory cycle. Each system has advantages and disadvantages arising from differing design features. Prescription should be based on individual tests in all cases to ensure optimal oxygen delivery during rest, exercise, and sleep.

Key words:
Oxygen conservation
Transtracheal catheter
Reservoir cannula
Demand oxygen delivery systems

Los sistemas de ahorro de oxígeno agrupan el catéter transtraqueal, las cánulas reservorio y los sistemas a demanda. Su objetivo es aumentar la autonomía de las fuentes de oxígeno portátiles consiguiendo una corrección de la hi-poxemia con menor flujo de oxígeno. El catéter transtraqueal aumenta la fracción inspiratoria de oxígeno al proporcionar oxígeno directamente en la tráquea, lo que evita el espacio muerto de la cavidad orofaríngea y favorece que la vía aérea superior actúe como reservorio. Las cánulas reservorio au-mentan la fracción inspiratoria de oxígeno al inicio de la ins-piración. Los sistemas a demanda cuentan con una válvula que se activa con la inspiración, de modo que se administra oxígeno sólo durante esta fase del ciclo respiratorio. Debido a sus diferentes características, cada sistema presenta venta-jas e inconvenientes. Para su correcta prescripción debe ajustarse individualmente el flujo de oxígeno tanto en reposo como durante el ejercicio o el sueño con las pruebas pertinentes.

Palabras clave:
Ahorro de oxígeno
Catéter transtraqueal
Cánulas reservorio
Sistemas a demanda
Full text is only aviable in PDF
REFERENCES
[1]
M Foster.
Lectures of the history of physiology, Cambridge University Press, (1901),
[2]
CW Scheele.
The discovery of oxygen.
Chemical treatise on air and fire (part 2), Alembic Club, (1902),
[3]
D McKie.
Antoine Lavoisier: scientist, economist, social reformer, Schumann, (1952),
[4]
SM Schultz, PM Hartmann, E George.
Holtzapple (1862-1946) and oxygen therapy for lobar pneumonia: the first reported case (1887) and a review of the contemporary literature to 1899.
J Med Biogr, 13 (2005), pp. 201-206
[5]
JS Haldane.
Symptoms, causes and prevention of anoxemia (and value of oxygen in its treatment).
Br Med J, (1919), pp. 65-71
[6]
AL Barach.
The therapeutic use of oxygen.
JAMA, 29 (1922), pp. 693-698
[7]
AL Barach.
Ambulatory oxygen therapy: oxygen inhalation at home and out-of-doors.
Chest, 35 (1959), pp. 229-241
[8]
JE Cotes, JC Gilson.
Effect of oxygen in exercise ability in chronic respiratory insufficiency: use of a portable apparatus.
Lancet, 1 (1956), pp. 822-826
[9]
EJM Campbell.
J. Burns Lecture: the management of acute respiratory failure in chronic bronchitis and emphysema.
Am Rev Resp Dis, 96 (1967), pp. 626-639
[10]
BE Levine, DB Bigelow, RD Hamstra, HJ Beckwitt, RS Mitchell, LM Nett, et al.
The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxemia.
Ann Intern Med, 66 (1967), pp. 639-650
[11]
AS Abraham, RB Cole, JM Bishop.
Reversal of pulmonary hypertension by prolonged oxygen administration to patients with chronic bronchitis.
Cir Res, 23 (1968), pp. 147-157
[12]
TL Petty, MN Finigan.
The clinical evaluation of prolonged ambulatory oxygen therapy in patients with chronic airway obstruction.
Am J Med, 45 (1968), pp. 242-252
[13]
TA Neff, TL Petty.
Long-term continuous oxygen therapy in chronic airway obstruction: mortality in relation to cor pulmonale, hypoxemia and hypercapnia.
Ann Intern Med, 72 (1970), pp. 621-626
[14]
Nocturnal Oxygen Therapy Trial.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease (a clinical trial).
Ann Intern Med, 93 (1980), pp. 391-398
[15]
Report of the Medical Research Council Working Party.
Long term domiciliary oxygen therapy in chronic cor pulmonale complicating chronic bronchitis and emphysema.
Lancet, 1 (1981), pp. 681-685
[16]
Crockett AJ, Cranston JM, Antic N.
Oxígeno domiciliario para la enfermedad pulmonar intersticial (Translated Cochrane review).
Update Software Ltd., (2005),
[17]
TL Petty.
Historical highlights of long-term oxygen therapy.
Respir Care, 45 (2000), pp. 29-36
[18]
A Andersson, K Strom, H Brodin, M Alton, G Bowan, P Jakobsson, et al.
Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis.
Eur Respir J, 12 (1998), pp. 1284-1289
[19]
Bradley JM, O'Neill B.
Oxígeno ambulatorio a corto plazo para la enfermedad pulmonar obstructiva crónica (Translated Cochrane review).
Update Software Ltd., (2005),
[20]
M Emtner, J Porszasz, M Burns, A Somfay, R Casaburi.
Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients.
Am J Respir Crit Care Med, 168 (2003), pp. 1034-1042
[21]
RW McCoy.
New technologies for lighter portable oxygen systems.
Respir Care, 47 (2002), pp. 879-881
[22]
T Hogan, M Carr, T Floren, M Schupp.
Long-term oxygen therapy: financial and future considerations.
Respir Manage, 18 (1988), pp. 21-24
[23]
LA Hoffman.
Novel strategies for delivering oxygen: reservoir cannula, device flow and transtracheal oxygen administration.
Respir Care, 39 (1994), pp. 363-377
[24]
BL Tiep, MI Lewis.
Oxygen conservation and oxygen-conserving devices in chronic lung disease.
Chest, 92 (1987), pp. 263-272
[25]
B Tiep.
Portable oxygen therapy with oxygen conserving devices and methodologies.
Monaldi Arch Chest Dis, 50 (1995), pp. 51-57
[26]
S Díaz-Lobato, C Villasante, J Villamor.
Beneficios que aporta la oxigenoterapia por catéter transtraqueal.
Med Clin (Barc), 100 (1993), pp. 264-265
[27]
KL Christopher, BT Spofford, MD Petrun, DC McCarty, JR Goodman, TL Petty.
A program for transtracheal oxygen delivery assessment of safety and efficacy.
Ann Intern Med, 107 (1987), pp. 802
[28]
J Benditt, M Pollock, J Roc, B Celli.
Transtracheal delivery of gas decreases the oxygen cost of breathing.
Am Rev Respir Dis, 147 (1993), pp. 1207-1210
[29]
C Domingo, J Klamburg, J Roig, R Coll, J Izquierdo, J Morera, et al.
Acute and long-term hemodynamic response to home oxygen therapy: nasal prongs versus oxygen saving devices.
J Appl Res, 4 (2004), pp. 149-163
[30]
KL Christopher, BT Spofford, PK Brannin, TL Petty.
Transtracheal oxygen therapy for refractory hipoxemia.
JAMA, 256 (1986), pp. 494
[31]
E Farrero.
Oxigenoterapia crónica domiciliaria.
Tratado de rehabilitación respiratoria, pp. 291-301
[32]
JH Heimlich, GC Carr.
Transtracheal catheter technique for pulmonary rehabilitation.
Ann Otol Rhinol Laryngol, 94 (1985), pp. 502-504
[33]
S Díaz-Lobato, M García Tejero, MA Racionero, F García Río, C Villasante, J Villamor, et al.
Oxigenoterapia deambulatoria por catéter transtraqueal.
Arch Bronconeumol, 32 (1996), pp. 225-229
[34]
MJ Kamplemacher, M Deenstra, RG van Kesteren, CF Melissant, JM Douze, JW Lammers.
Transtracheal oxygen therapy: an effective and safe alternative to nasal oxygen administration.
Eur Respir J, 10 (1997), pp. 828-833
[35]
BL Tiep, MJ Belman, C Mittman, R Phillips, B Otsap.
A new pendant storage oxygen-conserving nasal cannula.
Chest, 87 (1985), pp. 381-383
[36]
S Arlati, J Rolo, E Micallef, C Sacerdote, I Brambilla.
A reservoir nasal cannula improves protection given by oxygen during muscular exercise in COPD.
Chest, 93 (1988), pp. 1165-1169
[37]
RA Claiborne, DE Paynter, AK Dutt, JW Rowlands.
Evaluation of the use of an oxygen conservation device in long-term oxygen therapy.
Am Rev Respir Dis, 136 (1987), pp. 1095-1098
[38]
M Soffer, DP Tashkin, BJ Shapiro, M Littner, E Harvey, S Farr.
Conservation of oxygen supply using a reservoir nasal cannula in hypoxemic patients at rest and during exercise.
Chest, 88 (1985), pp. 663-668
[39]
P Collard, JP Wautelet, J Delwiche, J Prignot, P Dubois.
Improvement of oxygen delivery in severe hypoxaemia by a reservoir cannula.
Eur Respir J, 2 (1989), pp. 778-781
[40]
C Fuhrman, C Chouaid, R Herigault, B Housset, S Adnot.
Comparison of four demand oxygen delivery systems at rest and during exercise for chronic obstructive pulmonary disease.
Respir Med, 98 (2004), pp. 938-944
[41]
BL Tiep, J Barnett, G Schiffman, O Sánchez, R Carter.
Maintaining oxygenation via demand oxygen delivery during rest and exercise.
Respir Care, 47 (2002), pp. 887-892
[42]
R Garrod, JC Bestall, E Paul, JA Wedzicha.
Evaluation of pulsed dose oxygen delivery during exercise in patients with severe chronic obstructive pulmonary disease.
Thorax, 54 (1999), pp. 242-244
[43]
BL Tiep, R Carter, B Nicotra, J Berry, RE Phillips, B Otsap.
Demand oxygen delivery during exercise.
Chest, 91 (1987), pp. 15-20
[44]
JS Bower, CJ Brook, K Zimmer, D Davis.
Performance of a demand oxygen saver system during rest, exercise, and sleep in hypoxemic patients.
Chest, 94 (1988), pp. 77-80
[45]
SR Braun, G Spratt, GC Scott, M Ellersieck.
Comparison of six oxygen delivery systems for COPD patients in rest and exercise.
Chest, 102 (1992), pp. 694-698
[46]
A Cuvelier, JF Muir, P Czernichow, E Vavasseur, F Portier, D Benhamou, et al.
Nocturnal efficiency and tolerance of a demand oxygen delivery system in COPD patients with nocturnal hypoxemia.
Chest, 116 (1999), pp. 22-29
[47]
F Morante, R Güell, M Mayos.
Eficacia de la prueba de los 6 minutos de marcha en la valoración de la oxigenoterapia de deambulación.
Arch Bronconeumol, 41 (2005), pp. 596-600
[48]
U Johann, J Fichter, GW Sybrecht.
Efficacy of demand oxygen delivery systems in patients with chronic obstructive lung disease.
Pneumologie, 55 (2001), pp. 306-310
[49]
P Bliss, RW McCoy, AB Adams.
Characteristics of demand oxygen delivery systems: maximum output and setting recommendations.
Respir Care, 49 (2004), pp. 160-165
[50]
L Puente-Maestu.
Las pruebas de marcha en la prescripción de la oxigenoterapia portátil.
Arch Bronconeumol, 41 (2005), pp. 591-592
[51]
B Lara, M Miravitlles.
Viajar con oxígeno. Reflexiones a propósito de la primera reunión internacional de pacientes con déficit de alfa-1-antitripsina.
Arch Bronconeumol, 40 (2004), pp. 144
Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?